BRIEF published on 07/03/2024 at 12:38, 4 months 17 days ago Alpha Financial Markets Consulting PLC: Amendment to Form 8.3 Disclosure Shares Form 8.3 Disclosure Apex Fundrock Alpha Financial
PRESS RELEASE published on 07/03/2024 at 12:33, 4 months 17 days ago Form 8.3 - Apex Fundrock Limited : AMENDMENT - FORM 8.3 - ALPHA FINANCIAL MARKETS CONSULTING PLC Chelverton Asset Management amends Form 8.3 disclosure for Apex Fundrock Limited relating to Alpha Financial Markets Consulting PLC shares holding Form 8.3 Apex Fundrock Limited Chelverton Asset Management Alpha Financial Markets Consulting PLC Disclosure Amendment
BRIEF published on 07/02/2024 at 13:27, 4 months 18 days ago Apex Fundrock Limited Discloses Position in Alpha Financial Markets Consulting plc Takeover Code Chelverton Asset Management Apex Fundrock Alpha Financial Stock Disclosures
PRESS RELEASE published on 07/02/2024 at 13:22, 4 months 18 days ago Form 8.3 - Apex Fundrock Limited : Re Alpha Financial Markets Consulting plc Chelverton Asset Management discloses ownership of 1.11% in Apex Fundrock Limited (MISL) per Form 8.3. Details of relevant securities holdings provided Form 8.3 Apex Fundrock Limited Chelverton Asset Management MISL Security Holdings
BRIEF published on 06/26/2024 at 11:56, 4 months 24 days ago Alpha Financial Markets Consulting: Apex Fundrock Limited Disclosure Securities Disclosure Apex Fundrock Alpha Financial Chelverton
PRESS RELEASE published on 06/26/2024 at 11:51, 4 months 24 days ago Form 8.3 - Apex Fundrock Limited : Re Alpha Financial Market Consulting plc Chelverton Asset Management discloses a 1.45% interest in Apex Fundrock Limited. No other party disclosures reported Apex Fundrock Limited Chelverton Asset Management Disclosures 1.45% Interest Public Position Disclosure
BRIEF published on 05/24/2024 at 11:35, 5 months 27 days ago Disclosure of Interests by Chelverton Asset Management in Alpha Financial Market Consulting PLC Takeover Code Securities Disclosure Chelverton Asset Management Alpha Financial Market Consulting
PRESS RELEASE published on 05/24/2024 at 11:30, 5 months 27 days ago Form 8.3 - Apex Fundrock Limited : Re Alpha Financial Market Consulting plc Chelverton Asset Management discloses a 1.74% interest in Apex Fundrock Limited. No other disclosures made. Date of disclosure: 24th May 2024 Form 8.3 Disclosure Apex Fundrock Limited Chelverton Asset Management Re Alpha Financial Market Consulting Plc
Published on 11/21/2024 at 10:03, 54 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 57 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 57 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 22 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 32 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 27 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 52 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 55 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 57 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 57 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 59 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 37 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 12 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 12 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
